Kintegral Advisory LLC Has $1.12 Million Stock Holdings in DaVita Inc. (NYSE:DVA)

Kintegral Advisory LLC reduced its holdings in shares of DaVita Inc. (NYSE:DVA) by 4.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,508 shares of the company’s stock after selling 350 shares during the quarter. Kintegral Advisory LLC’s holdings in DaVita were worth $1,123,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Franklin Resources Inc. boosted its stake in DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC boosted its position in shares of DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after buying an additional 154,061 shares during the last quarter. Atom Investors LP bought a new stake in DaVita during the third quarter worth $4,094,000. Assenagon Asset Management S.A. raised its position in DaVita by 201.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after buying an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new position in DaVita during the 3rd quarter valued at $726,000. 90.12% of the stock is owned by institutional investors.

DaVita Price Performance

Shares of NYSE:DVA opened at $142.33 on Friday. DaVita Inc. has a fifty-two week low of $120.78 and a fifty-two week high of $179.60. The company’s 50-day moving average is $161.03 and its 200 day moving average is $158.00. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The company has a market capitalization of $11.39 billion, a P/E ratio of 13.25, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94.

DaVita (NYSE:DVA) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on DVA shares. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.